97 related articles for article (PubMed ID: 16920219)
1. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.
Goodman A; Davies CW
Lung Cancer; 2006 Oct; 54(1):51-5. PubMed ID: 16920219
[TBL] [Abstract][Full Text] [Related]
2. Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis.
Fysh ET; Thomas R; Read CA; Kwan BC; Yap E; Horwood FC; Lee P; Piccolo F; Shrestha R; Garske LA; Lam DC; Rosenstengel A; Bint M; Murray K; Smith NA; Lee YC
BMJ Open; 2014 Nov; 4(11):e006757. PubMed ID: 25377015
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status.
Terra RM; Teixeira LR; Bibas BJ; Pego-Fernandes PM; Vargas FS; Jatene FB
Clinics (Sao Paulo); 2011; 66(2):211-6. PubMed ID: 21484035
[TBL] [Abstract][Full Text] [Related]
4. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.
Dresler CM; Olak J; Herndon JE; Richards WG; Scalzetti E; Fleishman SB; Kernstine KH; Demmy T; Jablons DM; Kohman L; Daniel TM; Haasler GB; Sugarbaker DJ; ; ; ;
Chest; 2005 Mar; 127(3):909-15. PubMed ID: 15764775
[TBL] [Abstract][Full Text] [Related]
5. Resource Use and Costs of Indwelling Pleural Catheters versus Pleurodesis for Malignant Pleural Effusions: A Population-based Study.
Kwok C; Thavorn K; Amjadi K; Aaron SD; Kendzerska T
Ann Am Thorac Soc; 2024 Jun; 21(6):940-948. PubMed ID: 38381853
[No Abstract] [Full Text] [Related]
6. Randomized Controlled Trial of Thresholds for Drain Removal After Anatomic Lung Resection.
Gioutsos K; Ehrenreich L; Azenha LF; Quapp CS; Kocher GJ; Lutz JA; Peischl S; Dorn P
Ann Thorac Surg; 2024 Jun; 117(6):1103-1109. PubMed ID: 37734641
[TBL] [Abstract][Full Text] [Related]
7. Ghost chest tube after talc pleurodesis.
Matsumoto T; Kusakabe Y; Yamamoto N; Aihara K
Clin Case Rep; 2020 Nov; 8(11):2306-2307. PubMed ID: 33235786
[TBL] [Abstract][Full Text] [Related]
8. The future of chemical pleurodesis: A review of novel and investigational sclerosant agents.
Glatt J; Chandar P
Am J Med Sci; 2024 Apr; ():. PubMed ID: 38670530
[TBL] [Abstract][Full Text] [Related]
9. Comparison between pleurodesis results by 50% glucose solution, versus Bleomycin pleurodesis in patients with malignant pleural effusion.
Talebzadeh H; Nazari Sabet M
Int J Physiol Pathophysiol Pharmacol; 2023; 15(5):134-141. PubMed ID: 38022726
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
11. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial.
Psallidas I; Piotrowska HEG; Yousuf A; Kanellakis NI; Kagithala G; Mohammed S; Clifton L; Corcoran JP; Russell N; Dobson M; Miller RF; Rahman NM
BMJ Open Respir Res; 2017; 4(1):e000225. PubMed ID: 29225889
[TBL] [Abstract][Full Text] [Related]
13. Pleural procedures in the management of malignant effusions.
Ferreiro L; Suárez-Antelo J; Valdés L
Ann Thorac Med; 2017; 12(1):3-10. PubMed ID: 28197215
[TBL] [Abstract][Full Text] [Related]
14. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
[TBL] [Abstract][Full Text] [Related]
15. Management of malignant pleural effusion by an indwelling pleural catheter: A cost-efficiency analysis.
Rial MB; Lamela IP; Fernández VL; Arca JA; Delgado MN; Pombo CV; Hernández CR; Fernández-Villar A
Ann Thorac Med; 2015; 10(3):181-4. PubMed ID: 26229560
[TBL] [Abstract][Full Text] [Related]
16. Interventional pulmonologist perspective: treatment of malignant pleural effusion.
Sweatt AJ; Sung A
Curr Treat Options Oncol; 2014 Dec; 15(4):625-43. PubMed ID: 25240411
[TBL] [Abstract][Full Text] [Related]
17. Developing a 'pleural team' to run a reactive pleural service.
Bhatnagar R; Maskell N
Clin Med (Lond); 2013 Oct; 13(5):452-6. PubMed ID: 24115700
[TBL] [Abstract][Full Text] [Related]
18. Management of malignant pleural effusion.
Kastelik JA
Lung; 2013 Apr; 191(2):165-75. PubMed ID: 23315213
[TBL] [Abstract][Full Text] [Related]
19. Management of malignant pleural effusion.
Chen H; Brahmer J
Curr Oncol Rep; 2008 Jul; 10(4):287-93. PubMed ID: 18778553
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
